Greg Allen, MD/PhD is a physician-scientist specializing in designing and translating next-generation immune cell therapies for solid tumors. He cares for patients with lung cancer at the Hellen Diller Cancer Center and runs a research laboratory at the Parker Institute for Cancer Immunotherapy.
The Allen Lab is focused on developing and applying advanced synthetic biology tools to dissect the fundamental design principles of the immune system. We use synthetic receptors, cytokines, and secondary messengers to generate novel alternatively engineered tumor-immune eco-systems, which we then interrogate with high-dimensional tools. From this ground-up systems biology perspective we are attempting to rationally design engineered cells to tackle the most challenging diseases we face in the clinic.